Handelsavisen
prelaunch
06
0677.HK HKEX Food Retail & Distribution

0677.Hk

HK$0,34
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
568,6M HKD
P/E
EV / Rev
Div yield
6,48 %
Op margin
0,2 %
ROE
-1,1 %
Net margin
-0,7 %
Debt / equity
0,38
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.

Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Drug Retailing
IndustryFood Retail & Distribution
ActivityFood & Drug Retailing
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-1,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 0677.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 0677.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Drug Retailing
    IndustryFood Retail & Distribution
    ActivityFood & Drug Retailing
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position. Its liquidity is assessed as medium, with a current ratio of 1.72, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's price-to-book ratio of 0.46 and price-to-tangible-book ratio of 0.46 indicate that the market values the company's equity at a discount to its book value.

    Profitability metrics show a mixed picture. The company reported a net loss of -14,466,000 HKD, resulting in a negative return on equity of -1.14% and a negative return on assets of -0.69%. These figures are below the typical performance of the industry, which generally expects positive returns on equity and assets. The company's gross profit of 794,496,000 HKD and operating income of 4,699,000 HKD suggest some level of operational efficiency, but the net loss indicates significant non-operational expenses or challenges.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher concentration risk, particularly if demand in its primary market fluctuates.

    Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific outlook figures for the current or next fiscal year, but the negative net income and low profitability metrics suggest potential challenges in achieving revenue growth. The company's operating cash flow of 262,124,000 HKD and free cash flow of 78,796,000 HKD indicate some capacity to fund operations and investments, but the negative net income may limit long-term growth prospects.

    Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's capital structure and financial performance suggest that it may need to manage its debt and improve profitability to sustain operations and growth.

    Recent events and filings do not provide specific details on new initiatives or strategic changes. The company's financial performance and risk profile suggest that it may need to address operational inefficiencies and improve its financial health to meet its long-term objectives.

    Key takeaways
    • The company has a conservative debt-to-equity ratio of 0.38, indicating a relatively low leverage position.
    • The company's profitability is weak, with a negative return on equity of -1.14% and a negative return on assets of -0.69%.
    • The company's liquidity is assessed as medium, with a current ratio of 1.72.
    • The company's revenue is concentrated in a single business segment, increasing its exposure to market fluctuations.
    • The company's net cash is negative after subtracting total debt, indicating potential liquidity challenges.
    • The company's growth trajectory is uncertain, with no specific outlook figures provided for the current or next fiscal year.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$0,34
    Market cap
    HK$585.6M
    Enterprise value
    HK$1.07B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    4.1x
    P / B
    0.5x
    P / Tangible book
    0.5x
    Tangible book
    HK$1.27B
    Net cash
    -HK$481.5M
    Current ratio
    1.7
    Debt / equity
    0.4
    ROA
    -0.7%
    ROE
    -1.1%
    Cash conversion
    -1812.0%
    CapEx / revenue
    -3.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin0,2 %Bottom quartile
    Net Margin-0,7 %Bottom quartile
    ROE-1,1 %Bottom quartile
    Capex / Rev-3,0 %Below median
    D/E0,38Above median
    Cash Conv-18,12Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • 0677.HK Market data — financials · 2026-05-26

    Ownership & reference

    Leadership

    • Laurent LamExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    0677.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage